Research
Scientific articles on peptide research, documentation, purity, and traceability.
Alpha Research
BPC 157
BPC-157 + TB-500 Combination: Synergistic Evidence in Preclinical Repair Models
Review of BPC-157 + TB-500 combination evidence in preclinical repair models: mechanistic bases of FAK/NO + G-actin/integrin complementarity, criteria for evaluating synergy versus addition, combined model data in tendon, muscle, and vascular tissue, and methodological considerations for combined experiment design.
Alpha Research
BPC 157
BPC-157 vs TB-500: Complementary Mechanisms in Tissue Repair Research
Comparative analysis of BPC-157 and TB-500 (Tβ4) as tissue repair research tools: differences in primary mechanism (FAK/NO vs. G-actin/integrin), tissue spectrum investigated, pharmacokinetic profile, and evidence of mechanistic complementarity in combined models.
Alpha Research
BPC 157
BPC-157 and the Gut-Brain Axis: Cytoprotection, COX-2 Modulation, and Mucosal Healing Models
Analysis of BPC-157 gastrointestinal activity: gastric cytoprotection, biphasic COX-2 modulation, mucosal barrier preservation via occludin and claudin-4 upregulation, and gut-brain axis data in rodent colitis and ulcer models.
Alpha Research
BPC 157
BPC-157 and Tissue Repair: FAK/Paxillin Signaling and Nitric Oxide Pathway Activation
Mechanistic analysis of BPC-157 activity in tissue repair models: FAK phosphorylation at Tyr397, paxillin recruitment, Rac1/Cdc42 activation, VEGFR2 upregulation, and NO production in HUVEC. Quantitative data from tendon, muscle, and vascular tissue models.
Alpha Research
BPC 157
BPC-157: Mechanism, Receptor Interactions, and Preclinical Data Summary
Preclinical review of BPC-157 (Body Protection Compound-157): a synthetic gastric pentadecapeptide with documented activity on FAK/paxillin pathways, nitric oxide signaling, and angiogenesis. Summary of in vitro and in vivo models, pharmacokinetic parameters, and quality standards for research.